The price of DBD is predicted to go up 8.16%, based on the high correlation periods with XPRO. The similarity of these two price pattern on the periods is 94.07%.

DBD

XPRO

Up: 8.16%Similarity: 94.07%

DBD Revenue Forecast

DBD EPS Forecast

DBD FAQs

What is bull’s view on DBD?

DBD stock is currently trading at $43.86, near the lower end of its 52-week range, and its RSI of 28.4 suggests it is oversold, indicating a potential rebound opportunity. Bulls argue that the stock is undervalued with a Forward P/E of 8.09, significantly below the industry average, and may see upside if earnings on February 12, 2025, exceed expectations. However, the projected EPS decline of 60.93% year-over-year tempers enthusiasm, making this a cautious bullish case.

What is bear's view on DBD?

DBD stock is currently trading at $43.86, near the midpoint of its 52-week range ($28.16–$51.81). The bearish view stems from its projected 60.93% year-over-year EPS decline and a 5% revenue drop in the upcoming February 12 earnings report, coupled with a Zacks Rank #5 (Strong Sell), indicating negative sentiment. Despite undervaluation (Forward P/E of 10.82 vs. industry average of 32.84), weak earnings outlook and underperformance relative to the sector suggest caution.